Hepatitis B virus infection and hepatocellular carcinoma in PLWH: Epidemiology, pathogenesis and treatment Review


Authors: D'Andrea, F.; Venanzi Rullo, E.; Marino, A.; Moscatt, V.; Celesia, B. M.; Cacopardo, B.; Condorelli, F.; La Rocca, G.; Di Rosa, M.; Pellicano, G. F.; Nunnari, G.; Ceccarelli, M.
Review Title: Hepatitis B virus infection and hepatocellular carcinoma in PLWH: Epidemiology, pathogenesis and treatment
Abstract: Combined Antiretroviral therapy altered the natural history of Human Immunodeficiency Virus (HIV) infection, leading to a substantial decline in morbidity and mortality of patients living with HIV. Due to the shared transmission routes, co-infection with HBV and HIV is not uncommon, especially in those patients with similar socioeconomic vulnerabilities and psycho-social conditions. HBV is a known cause of HCC even in absence of cirrhosis, and HIV-HBV-coinfected patients may have faster progression of hepatic fibrosis and a higher risk of cirrhosis and consequently HCC. In this article we review the epidemiology, the etiology, the role of coinfection HIV/HBV in the pathogenesis of liver cancer, the management and prevention of HBV infection in HIV-infected patients in the era of combined antiretroviral treatment.
Keywords: liver; hiv; cells; disease; kaposis-sarcoma; malignancies; hcc; viral clearance; therapeutic management; coinfection; cancer; pregnant-women; hbv; b hepatitis
Journal Title: World Cancer Research Journal
Volume: 7
ISSN: 2372-3416
Publisher: Verduci Publisher  
Date Published: 2020-01-01
Start Page: e1537
Language: English
ACCESSION: WOS:000518444400001
PROVIDER: wos
DOI: 10.32113/wcrj_20203_1537
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors